Toll-like receptors (TLR2 and TLR4) antagonist mitigates the onset of cerebral small vessel disease through PI3K/Akt/GSK3β pathway in stroke-prone renovascular hypertensive rats
Author:
Affiliation:
1. Department of Neurology inspection, the people’s Hospital of Liaoning Province, Liaoning, P.R, China
2. Department of Neurology inspection, the Jinqiu Hospital of Liaoning Province, Liaoning, P.R, China
Funder
the Shenyang Science and Technology Plan Project
the Liaoning natural fund project
Publisher
Informa UK Limited
Subject
Molecular Biology,Bioengineering,Biotechnology
Link
https://www.tandfonline.com/doi/pdf/10.1080/02648725.2023.2184961
Reference39 articles.
1. Inflammation and Stroke: An Overview
2. Los niveles de expresión de los receptores toll-like 2 y 4 en neutrófilos se asocian con el pronóstico de los pacientes con ictus isquémico
3. Toll-Like Receptor 4 Is Involved in Brain Damage and Inflammation After Experimental Stroke
4. Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia
5. Hydroxysafflor Yellow A Protects Against Cerebral Ischemia–Reperfusion Injury by Anti-apoptotic Effect Through PI3K/Akt/GSK3β Pathway in Rat
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. TAK-3 Inhibits Lipopolysaccharide-Induced Neuroinflammation in Traumatic Brain Injury Rats Through the TLR-4/NF-κB Pathway;Journal of Inflammation Research;2024-04
2. Crosstalk Among Glial Cells in the Blood–Brain Barrier Injury After Ischemic Stroke;Molecular Neurobiology;2024-01-27
3. Research Progress of Toll-Like Receptors in Stroke Disease;Advances in Clinical Medicine;2024
4. Study on Undercarboxylated Osteocalcin in Improving Cognitive Function of Rats with Type 2 Diabetes Mellitus by Regulating PI3K-AKT-GSK/3β Signaling Pathwaythrough medical images;Biotechnology and Genetic Engineering Reviews;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3